Avalon Globocare (AVCO) Stock: Soaring On Breakthrough

Avalon Globocare Corp (NASDAQ: AVCO) is having an incredibly strong start to the trading session this morning after the company announced that it has achieved a breakthrough. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about: The breakthrough; what we’re seeing from AVCO stock as … Read more

Apellis Pharmaceuticals (APLS) Stock: Headed Up On Fast Track Designation

Apellis Pharmaceuticals Inc (NASDAQ: APLS) is having a great start to the trading session this morning, and for good reason. The company announced that it has received Fast Track designation from the FDA for one of its clinical candidates. As you could imagine, the news excited investors, pushing the stock on a run for the … Read more

Biocept (BIOC) Stock: Climbing On New Agreement

Biocept Inc (NASDAQ: BIOC) is flying early on in the trading session this morning, and for good reason. The company announced a new agreement surrounding its liquid biopsy technology that excited investors, sending the stock running up. Today, we’ll talk about: The new agreement; what we’re seeing from BIOC stock as a result; and what … Read more

Atossa Genetics (ATOS) Stock: Gaining On Expanded Access Results

Atossa Genetics Inc (NASDAQ: ATOS) is having a great start to the trading session this morning, and for good reason. The company announced positive results from the expanded access program surrounding a clinical-stage product. With the positive news in mind, excited investors are pushing the stock on a run for the top. Today, we’ll talk … Read more

MacroGenics (MGNX) Stock: Running Up On Clinical Data

MacroGenics Inc (NASDAQ: MGNX) is flying early on in the pre-market hours this morning, and for good reason. The company announced positive clinical data from a Phase 3 trial, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The data; what we’re seeing from MGNX stock as a … Read more

Synergy Pharmaceuticals (SGYP) Stock: The Details of the Deal

Synergy Pharmaceuticals (NASDAQ: SGYP) has been an interesting stock to follow as of late. With a stalking horse bid in, but few details available, investors are debating about whether or not this is a good deal. Well, there are a couple of things that I can say here. First and foremost, it’s a win/win for … Read more

Med-X: Why Investors Should Be Paying Attention

The world is changing, and so too are opinions. Today, opinions with regard to cannabis, pharmaceuticals, chemicals, and more are constantly being scrutinized. Med-X is a company that is riding on the leading edge of this change and creating a compelling opportunity in the process. What Is Med-X Med-X is a company that is becoming … Read more

BioTech Stocks | Watch AMRN, MNKD, HLF, GILD & GENE

While I just jumped into watching BioTech stocks relatively recently, I’m really enjoying the market. With that said, I’ve picked out a few that I’ll be watching closely tomorrow; and I figured I’d share them in advance. So, here they are… # 1: In BioTech Stocks To Watch: Amarin (NASDAQ: AMRN) Amarin (NASDAQ: AMRN) stocks … Read more